mdtalk | Redefining Clinical Trials & Innovating For Health Equity With Adam Samson - Episode 8

This episode focuses on disparity in clinical trial participation between patient populations, industry innovations to improve health equity, the accelerated movement towards decentralised trials – and what all this means for patient accessibility, diversity and engagement. 

 

Our host LaQuinta Jernigan, Chief Operating Officer at mdgroup, speaks with Adam Samson, Head of Clinical Delivery Operations, RWE Clinical Trials at Walgreens, to understand the importance of trial design for health equity.

 

Adam is an expert at conducting clinical trials across multiple therapeutic areas as a coordinator, monitor, project manager, and executive within academia, sites, CROs, pharma, tech, and retail pharmacy. He currently serves as Head of Clinical Delivery Operations at Walgreens where his primary role is to operationalise existing locations to conduct clinical trials.

 

Adam also serves as adjunct faculty at The George Washington University in the Master's in Clinical Research Administration program, as well as serving as a core member in the Decentralized Trials & Research Alliance (DTRA) working group to map the participant journey in decentralised clinical trials.